XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)

R.L. Ferris*, H. Mehanna, J.D. Schoenfeld, M. Tahara, S.S. Yom, R.I. Haddad, A. König, S. Salmio, M. Bajars, C. Le Tourneau

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)'. Together they form a unique fingerprint.

Medicine & Life Sciences